Interventional Cardiology

Endovascular Therapy

Structural Heart Disease

Mechanical Circulatory Support

Drug Eluting Stents

Paclitaxel Eluting Stent
Infinnium® Paclitaxel Eluting Stent

CE approved

The Infinnium® Paclitaxel Eluting Stent features a biodegradable polymer that is fully absorbed after 7 months. The proven drug Paclitaxel selectively inhibits smooth muscles cells* and thus favors rapid re-endothelialization.

*Limus drugs inhibit both smooth muscle cells
  AND endothelial cells.

Key Features*:

> complete Paclitaxel elution in 48 days
> competitive late lumen loss:
   in-stent 0.38 mm, in-segment 0.18 mm @ 9M
> no residual polymer after 7 months
> low crossing profile: 0.036" for 3.0 mm
   *Lemos et al.: PAINT Trial
> manufactured by Sahajanand Medical Technologies Pvt. Ltd.

Simvastatin Eluting Stent
Irist® Simvastatin Eluting Stent

CE approved

The Irist® DES is the first stent eluting the non-toxic drug simvastatin. Together with its anti-inflammatory P-5 triflusal based polymer the Irist® DES is designed for maximum DES safety.

Key Features*:

> complete simvastatin elution in 70 days
> MACE 7.1 %, TLR 4.3 % @ 9M
> binary restenosis 4.5 % @ 9M
> in-stent late lumen loss 0.63 mm @ 9M
   *Serra: IRIST I
> manufactured by Iberhospitex - Cordynamic
Design: Copyright 2011 © AVIDAL
Programming: Copyright 2011-2015 © OSE Erfurt